Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2017 | 10-2016 | 07-2016 | 04-2016 | 01-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,460 | -3,051 | -2,546 | -10,446 | -7,872 |
| Depreciation Amortization | 127 | 87 | 45 | 156 | 114 |
| Accounts receivable | -714 | -577 | -314 | -282 | -1,078 |
| Accounts payable and accrued liabilities | -572 | -744 | -387 | 482 | 101 |
| Other Working Capital | -826 | -1,268 | -1,080 | 1,209 | -218 |
| Other Operating Activity | 3,207 | 2,998 | 1,843 | 2,473 | 3,100 |
| Operating Cash Flow | $-3,238 | $-2,555 | $-2,439 | $-6,408 | $-5,853 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -181 | -30 | -17 | -322 | -176 |
| Investing Cash Flow | $-181 | $-30 | $-17 | $-322 | $-176 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -18 | -12 | -6 | -24 | -17 |
| Common Stock Issued | 4,340 | 4,340 | 4,340 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -18 | -18 |
| Financing Cash Flow | $4,322 | $4,328 | $4,334 | $-42 | $-35 |
| Beginning Cash Position | 2,585 | 2,585 | 2,585 | 9,357 | 9,357 |
| End Cash Position | 3,488 | 4,328 | 4,463 | 2,585 | 3,293 |
| Net Cash Flow | $903 | $1,743 | $1,878 | $-6,772 | $-6,064 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,238 | -2,555 | -2,439 | -6,408 | -5,853 |
| Capital Expenditure | -181 | -30 | -17 | -322 | -176 |
| Free Cash Flow | -3,419 | -2,585 | -2,456 | -6,730 | -6,029 |